Concepedia

Xue Zhou

XZ

Statistics

Publications

17

Citations

1K

H-Index

15

Active since

2015

Affiliations

Roche (China)(Current)

Roche (Switzerland)

Shanghai Institute of Pharmaceutical Industry

Fudan University

University of Auckland

Xue Zhou is an author at Roche (China) specializing in viral hepatitis, antiviral therapy, and molecular virology.

Publications per year

2015–2024

17

Publications

17

Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms

Zheng Zhou, Taishan Hu, Xue Zhou et al. · Scientific Reports · 2017 · 150 citations · Full text

, , +17

A novel orally available small molecule that inhibits hepatitis B virus expression

H. Mueller, Steffen Wildum, Souphalone Luangsay et al. · Journal of Hepatology · 2017 · 141 citations · Full text

, , +17

HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA

Zhipeng Yan, Jing Zeng, Youjun Yu et al. · Journal of Hepatology · 2017 · 82 citations

, , +9

Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors

Zongxing Qiu, Xianfeng Lin, Mingwei Zhou et al. · Journal of Medicinal Chemistry · 2016 · 75 citations · Full text

, , +17

Discovery of RG7834: The First-in-Class Selective and Orally Available Small Molecule Hepatitis B Virus Expression Inhibitor with Novel Mechanism of Action

Xingchun Han, Chengang Zhou, Min Jiang et al. · Journal of Medicinal Chemistry · 2018 · 74 citations · Full text

, , +17

1–5 of 17